Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract

Chlamydia Infection Clinical Trial

Official title:

Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT00578188
• Other study ID #: IRB # 43921
• Secondary ID: ACH GL #039005
• Status: Withdrawn
• Phase: N/A
• First received: December 19, 2007
• Last updated: April 12, 2016
• Start date: February 2006
• Est. completion date: January 2008

Study information

• Verified date: April 2016
• Source: Arkansas Children's Hospital Research Institute
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine if Chlamydial infections persist in the rectum of females who have had a sexually transmitted infection of Chlamydia.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: January 2008
• Est. primary completion date: January 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 11 Years to 19 Years

Eligibility

Inclusion Criteria:

• 11-19 years old

• Female

• Diagnosis of Chlamydia on enrollment visit

• Invitation to participate control group

Exclusion Criteria:

• Age out of range

• Negative Chlamydia screen (unless qualifies for control group)

• Unable to provide needed samples

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Chlamydia Infection
• Chlamydia Infections

Locations

Country	Name	City	State
United States	Arkansas Children's Hospital	Little Rock	Arkansas

Sponsors (1)

Lead Sponsor	Collaborator
Arkansas Children's Hospital Research Institute

Country where clinical trial is conducted

United States, 

References & Publications (5)

Centers for Disease Control and Prevention (CDC). Chlamydia trachomatis genital infections--United States, 1995. MMWR Morb Mortal Wkly Rep. 1997 Mar 7;46(9):193-8. — View Citation

Cotter TW, Ramsey KH, Miranpuri GS, Poulsen CE, Byrne GI. Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect Immun. 1997 Jun;65(6):2145-52. — View Citation

Dean D, Suchland RJ, Stamm WE. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis. 2000 Sep;182(3):909-16. Epub 2000 Aug 17. — View Citation

Igietseme JU, Portis JL, Perry LL. Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae. Infect Immun. 2001 Mar;69(3):1832-40. — View Citation

Jones RB, Rabinovitch RA, Katz BP, Batteiger BE, Quinn TS, Terho P, Lapworth MA. Chlamydia trachomatis in the pharynx and rectum of heterosexual patients at risk for genital infection. Ann Intern Med. 1985 Jun;102(6):757-62. — View Citation

External Links

•   Arkansas Children's Hospital Main Page